Literature DB >> 16371320

Behavioral alterations in Lewis rats following two-day continuous 3-nitropropionic acid administration.

J D Newcomb1, W D Brown, A I Rodriguez, S Garbuzova-Davis, S Saporta, P R Sanberg, A E Willing.   

Abstract

The mitochondrial toxin, 3-nitropropionic acid (3-NP), produces motor dysfunction and striatal atrophy in rats. However, rat strain and method of administration may contribute to variability in the deficits caused by 3-NP toxicity. To evaluate this, changes in nocturnal spontaneous locomotor activity from chronic administration of 3-NP using an osmotic mini pump, were examined in the Lewis rats. Lewis rats were treated with 3-NP or saline for 2 days and behavior was tested daily for a 15 day period. Animals receiving 3-NP displayed significantly less spontaneous activity than animals in the saline group. 3-NP treated animals also weighed significantly less when compared to saline treated animals. These results demonstrate that even though there were no significant alterations in overt anatomical pathology, even short-term exposure to 3-NP produced significant effects. This short-term administration may present a potential paradigm for examination of sub-threshold neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16371320     DOI: 10.1007/BF03033979

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  30 in total

1.  Co-localization of the D1 dopamine receptor in a subset of DARPP-32-containing neurons in rat caudate-putamen.

Authors:  K C Langley; C Bergson; P Greengard; C C Ouimet
Journal:  Neuroscience       Date:  1997-06       Impact factor: 3.590

2.  Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid.

Authors:  M C Guyot; P Hantraye; R Dolan; S Palfi; M Maziére; E Brouillet
Journal:  Neuroscience       Date:  1997-07       Impact factor: 3.590

3.  Assay of succinate dehydrogenase activity by a colorimetric-continuous method using iodonitrotetrazolium chloride as electron acceptor.

Authors:  P Munujos; J Coll-Cantí; F González-Sastre; F J Gella
Journal:  Anal Biochem       Date:  1993-08-01       Impact factor: 3.365

4.  N-Acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury.

Authors:  C Demougeot; P Garnier; C Mossiat; N Bertrand; M Giroud; A Beley; C Marie
Journal:  J Neurochem       Date:  2001-04       Impact factor: 5.372

5.  The effect of aging on p38 signaling pathway activity in the mouse liver and in response to ROS generated by 3-nitropropionic acid.

Authors:  Ching-Chyuan Hsieh; John Papaconstantinou
Journal:  Mech Ageing Dev       Date:  2002-09       Impact factor: 5.432

6.  Hyperactivity and hypoactivity in a rat model of Huntington's disease: the systemic 3-nitropropionic acid model.

Authors:  C V Borlongan; T K Koutouzis; T B Freeman; R A Hauser; D W Cahill; P R Sanberg
Journal:  Brain Res Brain Res Protoc       Date:  1997-08

7.  Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat.

Authors:  E Brouillet; M C Guyot; V Mittoux; S Altairac; F Condé; S Palfi; P Hantraye
Journal:  J Neurochem       Date:  1998-02       Impact factor: 5.372

8.  Striatal and cortical neurochemical changes induced by chronic metabolic compromise in the 3-nitropropionic model of Huntington's disease.

Authors:  David Blum; Marie-Christine Galas; David Gall; Laetitia Cuvelier; Serge N Schiffmann
Journal:  Neurobiol Dis       Date:  2002-08       Impact factor: 5.996

9.  Intrastriatal 3-nitropropionic acid: a behavioral assessment.

Authors:  T K Koutouzis; C V Borlongan; T B Freeman; D W Cahill; P R Sanberg
Journal:  Neuroreport       Date:  1994-11-21       Impact factor: 1.837

10.  Widespread expression of Huntington's disease gene (IT15) protein product.

Authors:  A H Sharp; S J Loev; G Schilling; S H Li; X J Li; J Bao; M V Wagster; J A Kotzuk; J P Steiner; A Lo
Journal:  Neuron       Date:  1995-05       Impact factor: 17.173

View more
  3 in total

1.  Decreased striatal dopamine release underlies increased expression of long-term synaptic potentiation at corticostriatal synapses 24 h after 3-nitropropionic-acid-induced chemical hypoxia.

Authors:  Garnik Akopian; Cynthia Crawford; M Flint Beal; Maurand Cappelletti; Michael W Jakowec; Giselle M Petzinger; Ling Zheng; Stacey L Gheorghe; Carmela M Reichel; Robert Chow; John P Walsh
Journal:  J Neurosci       Date:  2008-09-17       Impact factor: 6.167

Review 2.  Neurotoxins and neurotoxicity mechanisms. An overview.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

Review 3.  Cell therapies: careful translation from animals to patients.

Authors:  Sean I Savitz
Journal:  Stroke       Date:  2013-06       Impact factor: 7.914

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.